Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy

Clinical Infectious Diseases

Volumn 44, Issue 4, 2007, Pages 584-590

  Sheng, Wang Huei ^a   Hung, Chien Ching ^a   Wu, Ruei Jiuan ^a   Wang, Jann Tay ^a   Chen, Pei Jer ^b   Chang, Shan Chwen ^a   Kao, Jia Horng ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HEPATITIS B CORE ANTIBODY; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE TRANSMISSION; FEMALE; HEPATITIS G VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; TAIWAN; TREATMENT RESPONSE; VIREMIA; VIRUS LOAD;

EID: 84984535747     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/511037     Document Type: Article

References (33)

1. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995; 1:564-9.
2. Alter HJ, Nakatsuji Y, Melpolder J, et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997; 336:747-54.
3. Berzsenyi MD, Bowden DS, Bailey MJ, et al. Male to male sex is associated with a high prevalence of exposure to GB virus C. J Clin Virol 2005; 33:243-6.
4. Rey D, Fraize S, Vidinic J, et al. High prevalence of GB virus C/hepatitis G virus RNA in patients infected with human immunodeficiency virus. J Med Virol 1999; 57:75-9.
5. Souza IE, Zhang W, Diaz RS, Chaloner K, Klinzman D, Stapleton JT. Effects of GB virus C on response to antiretroviral therapy in HIV-infected Brazilians. HIV Med 2006; 7:25-31.
6. Puig-Basagoiti F, Cabana M, Guilera M, et al. Prevalence and route of transmission of infection with a novel DNA virus (TTV), hepatitis C virus, and hepatitis G virus in patients infected with HIV. J Acquir Immune Defic Syndr 2000; 23:89-94.
7. Tillmann HL, Manns MP. GB virus-C infection in patients infected with the human immunodeficiency virus. Antiviral Res 2001; 52:83-90.
8. Lefrere JJ, Roudot-Thoraval F, Morand-Joubert L, et al. Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virological, and clinical progression of human immunodeficiency virus disease in co-infected persons. J Infect Dis 1999; 179:783-9.
9. Yeo AET, Matsumoto A, Hisada M, Shih JW, Alter HJ, Goedert JJ. Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Multicenter Hemophilia Cohort Study. Ann Intern Med 2000; 132:959-63.
10. Williams CF, Klinzman D, Yamashita TE, et al. Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med 2004; 350:981-90.
11. Xiang J, Wunschmann S, Diekema DJ, et al. Effect of co-infection with GB virus C on survival among patients with HIV infection. N Engl J Med 2001; 345:707-14.
12. Brumme ZL, Chan KJ, Dong WWY, et al. No association between GB virus-C viremia and virological or immunological failure after starting initial anti-retroviral therapy. AIDS 2002; 16:1929-33.
13. Bjorkman P, Flamholc L, Naucler A, Molnegren V, Wallmark E, Widell A. GB virus C during the natural course of HIV-1 infection: viremia at diagnosis does not predict mortality. AIDS 2004; 18:877-86.
14. Van der Bij AK, Kloosterboer N, Prins M, et al. GB virus C co-infection and HIV-1 disease progression: the Amsterdam Cohort Study. J Infect Dis 2005; 191:678-85.
15. Voirin N, Trepo C, Esteve J, et al. Effects of co-infection with hepatitis C virus and GB virus C on CD4 cell count and HIV-RNA level among HIV-infected patients treated with highly active anti-retroviral therapy. AIDS 2002; 16:1556-9.
16. Xiang J, Wunschmann S, Schmidt W, Shao J, Stapleton JT. Full-length GB virus C (hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells. J Virol 2000; 74:9125-33.
17. Thomas DL, Vlahov D, Alter HJ, et al. Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. J Infect Dis 1998; 177:539-42.
18. Rodriguez B, Woolley I, Lederman MM, Zdunek D, Hess G, Valdez H. Effect of GB virus C coinfection on response to antiretroviral treatment in human immunodeficiency virus-infected patients. J Infect Dis 2003; 187:504-7.
19. Antonucci G, Girardi E, Cozzi-Lepri A, et al. Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals. Antivir Ther 2005; 10:109-17.
20. Centers for Disease Control and Prevention. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41:1-19.
21. Kao JH, Chen W, Chen PJ, Lai MY, Chen DS. Liver and peripheral blood mononuclear cells are not major sites for GB virus-C/hepatitis G virus replication. Arch Virol 1999; 144:2173-83.
22. Wang JT, Tsai FC, Lee CZ, et al. A prospective study of transfusion-transmitted GB virus C infection: Similar frequency but different clinical presentation compared with hepatitis C virus. Blood 1996; 88:1881-6.
23. Lo SY, Ku CW, Ma HC, et al. Detection of serologic responses to GB virus C/hepatitis G virus infection. Int J Infect Dis 2002; 6:223-7.
24. Dai CY, Yu ML, Chang WY, et al. The prevalence of TT virus and GB virus C/hepatitis G virus infection in individuals with raised liver enzymes but without HBV or HCV infection in Taiwan. Epidemiol Infect 2002; 129:307-13.
25. Stark K, Doering CD, Bienzle U, et al. Risk and clearance of GB virus C/hepatitis G virus infection in homosexual men: a longitudinal study. J Med Virol 1999; 59:303-6.
26. Nerurkar VR, Chua PK, Hoffmann PR, Dashwood WM, Shikuma CM, Yanagihara R. High prevalence of GB virus C/hepatitis G virus infection among homosexual men infected with human immunodeficiency virus type 1: evidence for sexual transmission. J Med Virol 1998; 56:123-7.
27. Tillmann HL, Heiken H, Knapik-Botor A, et al. Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 2001; 345:715-24.
28. Tillmann HL, Kaiser T, Fox Z, et al., MaxCmin1 Trial Group. Impact of coinfection with HIV-1 and GB virus C in patients receiving a ritonavir-boosted HAART regimen: a substudy to the MaxCmin1 trial. J Acquir Immune Defic Syndr 2005; 40:378-80.
29. Xiang J, George SL, Wunschmann S, Chang Q, Klinzman D, Stapleton JT. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1α, MIP-1β, and SDF-1. Lancet 2004; 363:2040-6.
30. Nunnari G, Nigro L, Palermo F, et al. Slower progression of HIV-1 infection in persons with GB virus C co-infection correlates with an intact T-helper 1 cytokine profile. Ann Intern Med 2003; 139:26-30.
31. Toyoda H, Honda T, Katano Y, Goto H, Takamatsu J. Clearance of GB virus C during highly active antiretroviral therapy and course of HIV disease progression in HIV-infected patients with hemophilia. Eur J Clin Microbiol Infect Dis 2005; 24:645-6.
32. Kao JH, Chen PJ, Lai MY, et al. GB virus-C/hepatitis G virus infection in an area endemic for viral hepatitis, chronic liver disease, and liver cancer. Gastroenterology 1997; 112:1265-70.
33. Jilg W, Sieger E, Zachoval R, Schatzle H. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection-high percentage of carriers of hepatitis B and C virus. J Hepatol 1995; 23:14-20.